IHS Chemical Week

Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients

Cambrex reports huge fall in profits

6:50 AM MDT | August 1, 2013 | Deepti Ramesh

Cambrex (East Rutherford, NJ) reports a 77% fall in net profits for the second quarter, ended 30 June, compared with the year-ago quarter, to $2.27 million. Net sales for the second quarter decreased 19.3%, to $61.5 million, primarily because of lower sales of controled substances and generic active pharmaceutical ingredients, Cambrex says. For the first six months of 2013, Cambrex reports a 20.7% fall in profits, compared with the first six months of 2012, to $13.4 million. Net sales in the first-half decreased by 7.1%, to $135.9 million. “The...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Not an IHS Chemical Week subscriber yet?

Here's why you should be:

  • 31 issues of Chemical Week magazine a year in print or digital format
  • Real time news and analysis on chemweek.com 
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional or company focus
  • Global Outlook issue

Subscribe now


contact us | about us | privacy policy | sitemap

ihsCopyright © IHS, Inc.All rights reserved.Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa